STOCK TITAN

British American Tobacco (BTI) updates share schemes and capital

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

British American Tobacco p.l.c. filed a Form 6-K summarizing several January 2026 press releases on share-related matters and disclosures by senior managers. The filing also includes a Schedule 5 blocklisting six monthly return for its Sharesave Schemes.

For the period from 1 July 2025 to 31 December 2025, under Sharesave Scheme A, the company issued 38,298 ordinary shares of 25p each, leaving 74,993 shares still available under that blocklisting. Sharesave Scheme B had no shares issued in the period and retained its full 1,500,000 share balance.

As of the end of the period, British American Tobacco reported 2,312,454,501 ordinary shares of 25p each in issue, including 132,988,352 shares held in treasury.

Positive

  • None.

Negative

  • None.


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


 
FORM 6-K
 

 
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
 
February 2, 2026
 
Commission File Number: 001-38159


 
BRITISH AMERICAN TOBACCO P.L.C.
(Translation of registrant’s name into English)


 
Globe House
4 Temple Place
London WC2R 2PG
United Kingdom
(Address of principal executive office)


 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F               Form 40-F ☐
 
 
 

 

 
This report includes materials as exhibits that have been published and made available by British American Tobacco p.l.c. as of February 2, 2026.

EXHIBIT INDEX
 
Exhibit
 
Description
 
 
 
Exhibit 1

Press Release entitled “Schedule 5 - Blocklisting Six Monthly Return” dated January 2, 2026.
     
Exhibit 2
 
Press Release entitled “British American Tobacco p.l.c. (the “Company”) - Voting Rights and Capital” dated January 2, 2026.
     
Exhibit 3  
Press Release entitled “Transaction in own shares” dated January 5, 2026.
     
Exhibit 4   Press Release entitled “Transaction in own shares” dated January 6, 2026.
     
Exhibit 5
  Press Release entitled “Transaction in own shares” dated January 7, 2026.
     
Exhibit 6
  Press Release entitled “Transaction in own shares” dated January 8, 2026.
     
Exhibit 7
 
Press Release entitled “British American Tobacco p.l.c. (“the Company”) - Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them” dated January 8, 2026.
     
Exhibit 8
  Press Release entitled “Transaction in own shares” dated January 9, 2026.
     
Exhibit 9
  Press Release entitled “Transaction in own shares” dated January 12, 2026.
     
Exhibit 10
  Press Release entitled “Transaction in own shares” dated January 13, 2026.
     
Exhibit 11   Press Release entitled “Transaction in own shares” dated January 14, 2026.
     
Exhibit 12

Press Release entitled “Transaction in own shares” dated January 15, 2026.
     
Exhibit 13   Press Release entitled “Transaction in own shares” dated January 16, 2026.
     
Exhibit 14   Press Release entitled “Transaction in own shares” dated January 19, 2026.
     
Exhibit 15   Press Release entitled “Transaction in own shares” dated January 20, 2026.
     
Exhibit 16   Press Release entitled “Transaction in own shares” dated January 21, 2026.
     
Exhibit 17
  Press Release entitled “Transaction in own shares” dated January 22, 2026.
     
Exhibit 18
  Press Release entitled “Transaction in own shares” dated January 26, 2026.
     
Exhibit 19   Press Release entitled “British American Tobacco p.l.c. - TR-1: Notification of major holdings” dated January 26, 2026.
     
Exhibit 20
  Press Release entitled “Transaction in own shares” dated January 27, 2026.

   
Exhibit 21

Press Release entitled “Transaction in own shares” dated January 28, 2026.
     
Exhibit 22   Press Release entitled “Transaction in own shares” dated January 29, 2026.
     
Exhibit 23   Press Release entitled “Transaction in own shares” dated January 30, 2026.




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
British American Tobacco p.l.c.
 
   
 
       
 
By:
/s/ Nancy Jiang
 
    Name: 
Nancy Jiang
 
    Title:   
Senior Assistant Company Secretary
 
       
 
Date:  February 2, 2026







Exhibit 1

SCHEDULE 5
 
BLOCKLISTING SIX MONTHLY RETURN 
 
1. Name of company
 
BRITISH AMERICAN TOBACCO P.L.C.
 
2. Name of scheme
 
A)          BRITISH AMERICAN TOBACCO P.L.C. Sharesave Scheme - 1,500,000 Ordinary shares of 25p each (Ref: 0287580) (GB0002875804)
 
B)          BRITISH AMERICAN TOBACCO P.L.C. Sharesave Scheme - 1,500,000 Ordinary shares of 25p each (Ref: 0287580) (GB0002875804)
 
3. Period of return: 
 
From 1 July 2025 to 31 December 2025
 
4. Balances under scheme from previous return:
 
A)          113,291
 
B)          1,500,000
 
5. The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return:
 
A)          N/A
 
B)          N/A
 
6. Number of securities issued/allotted under scheme during period:
 
A)          38,298
 
B)          0
 
7. Balance under scheme not yet issued/allotted at end of period:
 
A)          74,993
 
B)          1,500,000
 
8. Number and class of securities originally listed and the date of admission:
 
A)          1,500,000 listed on 01.05.15 (REF: 0287580) (GB0002875804)
 
B)          1,500,000 listed on 03.03.25 (REF: 0287580) (GB0002875804)
 
9. Total number of securities in issue at the end of the period:
 
2,312,454,501 Ordinary Shares of 25p each which figure includes 132,988,352 shares held in Treasury.
 

 
Contact for queries:
 
Name: C. Worlock
 
Address: Globe House, 4 Temple Place, London WC2R 2PG
 
Telephone: +44 20 7845 1976
 
Date: 2 January 2026

FAQ

What does British American Tobacco (BTI) disclose in this Form 6-K?

British American Tobacco p.l.c. files a Form 6-K summarizing multiple share-related press releases and a blocklisting six monthly return. It covers employee share schemes, transactions in its own shares, voting rights, capital information, and notifications of major holdings and managerial transactions.

What is the Schedule 5 blocklisting six monthly return for BTI?

The Schedule 5 blocklisting six monthly return reports activity under British American Tobacco’s Sharesave Schemes for six months. It details balances from the prior return, shares issued or allotted in the period, remaining blocklisted capacity, and the company’s total ordinary shares in issue at period end.

How many Sharesave Scheme A securities were issued by British American Tobacco?

Under Sharesave Scheme A, British American Tobacco issued 38,298 ordinary shares of 25p each during the period. This reduced the scheme’s remaining blocklisted balance from 113,291 shares to 74,993 shares between 1 July 2025 and 31 December 2025.

What are British American Tobacco’s total shares in issue and treasury shares?

British American Tobacco reports 2,312,454,501 ordinary shares of 25p each in issue at period end. This total includes 132,988,352 shares held in treasury, which are issued shares the company holds itself rather than being in public circulation.

Which share-related announcements are referenced in British American Tobacco’s 6-K exhibits?

The 6-K lists multiple January 2026 press releases on share matters. These include “Transaction in own shares” announcements on several dates, a voting rights and capital update, a notification of major holdings, and disclosures of transactions by persons discharging managerial responsibilities.
British Amer

NYSE:BTI

BTI Rankings

BTI Latest News

BTI Latest SEC Filings

BTI Stock Data

130.68B
2.18B
5.28%
12.95%
0.37%
Tobacco
Consumer Defensive
Link
United Kingdom
London